BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26902887)

  • 1. DNA methylation profiles in African American prostate cancer patients in relation to disease progression.
    Rubicz R; Zhao S; Geybels M; Wright JL; Kolb S; Klotzle B; Bibikova M; Troyer D; Lance R; Ostrander EA; Feng Z; Fan JB; Stanford JL
    Genomics; 2019 Jan; 111(1):10-16. PubMed ID: 26902887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.
    Zhao S; Geybels MS; Leonardson A; Rubicz R; Kolb S; Yan Q; Klotzle B; Bibikova M; Hurtado-Coll A; Troyer D; Lance R; Lin DW; Wright JL; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Clin Cancer Res; 2017 Jan; 23(1):311-319. PubMed ID: 27358489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
    Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
    Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.
    Stott-Miller M; Zhao S; Wright JL; Kolb S; Bibikova M; Klotzle B; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1331-9. PubMed ID: 24718283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study.
    Cheng Y; Monteiro C; Matos A; You J; Fraga A; Pereira C; Catalán V; Rodríguez A; Gómez-Ambrosi J; Frühbeck G; Ribeiro R; Hu P
    Clin Epigenetics; 2018; 10():54. PubMed ID: 29692867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.
    Shui IM; Wong CJ; Zhao S; Kolb S; Ebot EM; Geybels MS; Rubicz R; Wright JL; Lin DW; Klotzle B; Bibikova M; Fan JB; Ostrander EA; Feng Z; Stanford JL
    Cancer; 2016 Jul; 122(14):2168-77. PubMed ID: 27142338
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Barry KH; Mohanty K; Erickson PA; Wang D; Shi J; Rose G; Cellini A; Clark K; Ambulos N; Yin J; Yan L; Poulin M; Meyer A; Zhang Y; Bentzen SM; Burke A; Hussain A; Berndt SI
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer.
    Creighton CJ; Zhang F; Zhang Y; Castro P; Hu R; Islam M; Ghosh S; Ittmann M; Kwabi-Addo B
    Epigenetics; 2023 Dec; 18(1):2180585. PubMed ID: 37279148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
    Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
    Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of epigenome-wide DNA methylation reveals novel smoking-related loci in African Americans.
    Liu J; Zhao W; Ammous F; Turner ST; Mosley TH; Zhou X; Smith JA
    Epigenetics; 2019 Feb; 14(2):171-184. PubMed ID: 30764717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential DNA Methylation in Prostate Tumors from Puerto Rican Men.
    Ruiz-Deya G; Matta J; Encarnación-Medina J; Ortiz-Sanchéz C; Dutil J; Putney R; Berglund A; Dhillon J; Kim Y; Park JY
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.